Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “De Novo Renal Transplant Recipient.”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00238953
What this trial is testing

Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in de Novo Kidney Transplant Recipients

Who this might be right for
Renal Transplantation
Novartis 30
Post-approval studies (Phase 4)Study completedNCT00306397
What this trial is testing

Pilot Study to Investigate a Steroid Free Immunosuppressive Regimen for Renal Transplant Recipients

Who this might be right for
Kidney Transplantation
University Hospital, Basel, Switzerland 100
Large-scale testing (Phase 3)Study completedNCT00154284
What this trial is testing

Everolimus in a Cyclosporine Microemulsion-free Regimen Compared to a Low-dose Cyclosporine Microemulsion Regimen, in de Novo Kidney Transplant Patients

Who this might be right for
Organ Transplantation, Renal Transplantation
Novartis 114
Post-approval studies (Phase 4)Study completedNCT02723591
What this trial is testing

To Compare the Effects of Immediate-release Tacrolimus and Astagraf XL on Donor-Specific Antibody (DSA) Formation and the Development of Immune Activation (IA) in de Novo Kidney Transplant Recipients

Who this might be right for
Kidney Transplantation
Astellas Pharma Global Development, Inc. 599
Large-scale testing (Phase 3)Study completedNCT06001320
What this trial is testing

De-novo Initiation of Letermovir vs Valganciclovir for Cytomegalovirus Prophylaxis in AA Kidney Transplant Recipients

Who this might be right for
Kidney Transplant; ComplicationsCMV
Virginia Commonwealth University 30
Post-approval studies (Phase 4)Ended earlyNCT00956293
What this trial is testing

Study to Evaluate the Efficacy, Safety and Tolerability of Everolimus in de Novo Renal Transplant Recipients Participating in the Eurotransplant Senior Program

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 207
Post-approval studies (Phase 4)Study completedNCT03713645
What this trial is testing

Dosing Strategies for de Novo Once-daily Extended Release Tacrolimus (LCPT) in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant
Temple University 36
Large-scale testing (Phase 3)Study completedNCT01023815
What this trial is testing

Once-a-day Regimen With Everolimus, Low Dose Cyclosporine and Steroids in Comparison With Steroid Withdrawal or Twice a Day Regimen With Everolimus, Low Dose Cyclosporine and Steroids.

Who this might be right for
de Novo Kidney Transplant RecipientsRenal Transplantation
Novartis 330
Post-approval studies (Phase 4)Study completedNCT01649427
What this trial is testing

Comparison of a Tacrolimus Hexal® Based Regimen Versus a Prograf® Based Regimen in de Novo Renal Transplant Recipients

Who this might be right for
Pharmacokinetics Study in de Novo Kidney Transplantation
Novartis Pharmaceuticals 73
Large-scale testing (Phase 3)Study completedNCT00413920
What this trial is testing

Efficacy and Safety of Enteric-coated Mycophenolate Sodium and Cyclosporine in Combination With and Without Steroids, in Adult Renal Transplant Recipients

Who this might be right for
Renal Transplantation
Novartis 222
Not applicableStudy completedNCT00079222
What this trial is testing

Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Cancer
Jonsson Comprehensive Cancer Center
Post-approval studies (Phase 4)Study completedNCT01802268
What this trial is testing

Planned Conversion From TAC to SRL-based Regimen in de Novo Kidney Transplant Recipients

Who this might be right for
Kidney Transplant
Helio Tedesco Silva Junior 320
Large-scale testing (Phase 3)Ended earlyNCT00311311
What this trial is testing

Study Comparing Effect On Carotid Atherosclerosis Following Conversion From Tacrolimus To Sirolimus Post-Transplant In Kidney Transplant Patients

Who this might be right for
AtherosclerosisKidney Failure
Pfizer 72
Early research (Phase 1)Ended earlyNCT01163799
What this trial is testing

A Pilot Study to Assess the Safety and Efficacy of Alefacept in de Novo Kidney Transplant Recipients

Who this might be right for
Transplant; Failure, Kidney
Northwestern University 9
Large-scale testing (Phase 3)Study completedNCT00239876
What this trial is testing

Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 140
Testing effectiveness (Phase 2)Study completedNCT00403416
What this trial is testing

Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months), in Renal Transplant Patients

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 215
Large-scale testing (Phase 3)Ended earlyNCT00284921
What this trial is testing

MYPROMS-ES02: Safety and Efficacy of Basiliximab, Cyclosporine Microemulsion and Enteric-coated Mycophenolate Sodium (EC-MPS) Versus EC-MPS and Steroid Therapy in Kidney Transplant Recipients Who Are Hepatitis C Positive

Who this might be right for
De Novo Kidney Transplant
Novartis Pharmaceuticals 60
Testing effectiveness (Phase 2)Study completedNCT02137239
What this trial is testing

Regimen Optimization Study

Who this might be right for
Kidney Transplantation
Bristol-Myers Squibb 58
Large-scale testing (Phase 3)Study completedNCT00239811
What this trial is testing

Long Term Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 684
Large-scale testing (Phase 3)Study completedNCT00238992
What this trial is testing

Study of Enteric-coated Mycophenolate Sodium (EC-MPS) With Steroid Withdrawal vs EC-MPS With Standard Steroid Regimen in de Novo Renal Transplant Recipients.

Who this might be right for
Kidney de Novo Transplant
Novartis Pharmaceuticals 144
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation